BACKGROUND Patients with heart failure with preserved ejection fraction have functional impairment resulting in
N early one-half of patients presenting with heart failure (HF) display normal or near normal left ventricular (LV) systolic function (1) . This condition has been defined as HF with preserved ejection fraction (HFpEF) and is associated with substantial mortality and morbidity (2, 3) . HFpEF is characterized by impaired LV diastolic function due to abnormal relaxation and increased chamber stiffness (4), caused by alterations in collagen metabolism with subsequent myocardial fibrosis as well as by changes in cardiomyocyte titin homeostasis, resulting in elevated LV diastolic filling pressures (5-7). In their daily lives, affected patients have exercise intolerance, resulting in reduced quality of life (8) . It is broadly accepted that hemodynamic parameters, determined mainly by LV function, during systole and/or diastole, are associated with the severity of exercise impairment in patients with HF (9, 10) . Our group and others have recently drawn attention to the right ventricle and its prognosis-limiting role in HFpEF (11) (12) (13) (14) . Parameters of right ventricular function (RVF) as well as those reflecting right ventricular (RV) afterload have not been examined in the context of physical activity so far.
Furthermore, although exercise intolerance and dyspnea are cardinal symptoms of HF, they may also be caused by a series of comorbid conditions known to be associated with HFpEF (e.g., chronic obstructive pulmonary disease, chronic kidney disease, obesity) (15, 16) . Taken together, the exact pathological mechanisms underlying exercise intolerance and breathlessness in this patient population are not fully understood.
We sought to identify hemodynamic and other patient-related variables that are asso- test with blood gas analysis, and right heart catheterization (RHC) followed by coronary angiography. Values are mean AE SD or n (%).
A ¼ mitral peak velocity of late filling; CA ¼ pulmonary arterial compliance; CAD ¼ coronary artery disease; CO ¼ cardiac output; COPD ¼ chronic obstructive pulmonary disease; DLCO ¼ diffusion capacity of the lung for carbon monoxide; DPG ¼ diastolic pressure gradient; E ¼ early mitral inflow velocity; E 0 ¼ early diastolic mitral annular velocity; FAC ¼ fractional area change; FEV1 ¼ forced expiratory volume in 1 s; GFR ¼ glomerular filtration rate; HbA1c ¼ glycated hemoglobin; HF ¼ heart failure; IVS ¼ interventricular septum; LA ¼ left atrial; LVEDD ¼ left ventricular end-diastolic diameter; LVEF ¼ left ventricular ejection fraction; NT-proBNP ¼ N-terminal pro-brain natriuretic peptide; NYHA ¼ New York Heart Association; PaCO2 ¼ partial pressure of carbon dioxide; PaO2 ¼ partial pressure of oxygen; PAP ¼ pulmonary artery pressure; PAWP ¼ pulmonary artery wedge pressure; PPP ¼ pulmonary pulse pressure; PVR ¼ pulmonary vascular resistance; RA ¼ right atrial; RAP ¼ right atrial pressure; RVEDD ¼ right ventricular end-diastolic diameter; RVF ¼ right ventricular function; SaO2 ¼ arterial saturation of oxygen; 6MWD ¼ 6-min walking distance; SV ¼ stroke volume; TAPSE ¼ tricuspid annular plane systolic excursion; TPG ¼ transpulmonary gradient; TSH ¼ thyroid-stimulating hormone. Furthermore, capillary partial pressure of oxygen was lower in these patients (p ¼ 0.030) ( Table 1) .
DETERMINANTS OF NYHA FUNCTIONAL CLASS. Logistic regression models to delineate variables associated with NYHA functional class are shown in Table 2 .
With respect to each parameter cluster, the following 
parameters: higher dPAP (p < 0.001). No relationship was encountered between NYHA functional class and parameters reflecting pulmonary function.
NYHA FUNCTIONAL CLASS AND OUTCOME. After a mean follow-up period of 21.9 AE 13.1 months, 64 patients (33.2%) reached the combined endpoint.
Sixteen patients died for cardiac reasons and 3 for other reasons (1 of stroke, 1 of pancreatic cancer, and 1 of complications due to catheterization, which was not registry related and was not performed at our referral center) (22) .
In and lower vital capacity (p ¼ 0.007) ( Table 3) .
In a separate analysis ( Table 1 .
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CONCLUSIONS
The present study shows the prognostic importance of NYHA functional class on outcomes in patients 
